522 related articles for article (PubMed ID: 14499790)
21. [Hemochromatosis--from an underdiagnosed curiosity to a common disease].
Hagve TA; Asberg A; Ulvik R; Borch-Iohnsen B; Thorstensen K
Tidsskr Nor Laegeforen; 2009 Apr; 129(9):863-6. PubMed ID: 19415085
[TBL] [Abstract][Full Text] [Related]
22. Hereditary hemochromatosis: screening and management.
Waalen J; Beutler E
Curr Hematol Rep; 2006 Mar; 5(1):34-40. PubMed ID: 16537044
[TBL] [Abstract][Full Text] [Related]
23. Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Kamble RT; Selby GB; Mims M; Kharfan-Dabaja MA; Ozer H; George JN
Biol Blood Marrow Transplant; 2006 May; 12(5):506-10. PubMed ID: 16635785
[TBL] [Abstract][Full Text] [Related]
24. Reversibility of hypogonadotropic hypogonadism in a patient with the juvenile form of hemochromatosis.
Angelopoulos NG; Goula A; Dimitriou E; Tolis G
Fertil Steril; 2005 Dec; 84(6):1744. PubMed ID: 16359978
[TBL] [Abstract][Full Text] [Related]
25. Hemochromatosis: association of severity of iron overload with genetic markers.
Barton JC; Harmon L; Rivers C; Acton RT
Blood Cells Mol Dis; 1996; 22(3):195-204. PubMed ID: 9075570
[TBL] [Abstract][Full Text] [Related]
26. Strategy for diagnosis and management in iron overload.
Solís-Herruzo JA
Rev Esp Enferm Dig; 2003 May; 95(5):351-7, 343-50. PubMed ID: 12828522
[TBL] [Abstract][Full Text] [Related]
27. Increased urinary excretion of 8-iso-prostaglandin F2alpha in patients with HFE-related hemochromatosis: a case-control study.
Kom GD; Schwedhelm E; Nielsen P; Böger RH
Free Radic Biol Med; 2006 Apr; 40(7):1194-200. PubMed ID: 16545687
[TBL] [Abstract][Full Text] [Related]
28. [Effectiveness of therapeutic erythrocytapheresis to achieve iron depletion in hereditary type 1 hemochromatosis: report of 30 cases].
Poullin P; Lefèvre PA
Transfus Clin Biol; 2011 Dec; 18(5-6):553-8. PubMed ID: 22019606
[TBL] [Abstract][Full Text] [Related]
29. Hemochromatosis. Early intervention can arrest iron overload.
Beare J
Adv Nurse Pract; 2002 Jun; 10(6):63-6. PubMed ID: 12400365
[No Abstract] [Full Text] [Related]
30. H63D homozygotes with hyperferritinaemia: Is this genotype, the primary cause of iron overload?
de Diego C; Opazo S; Murga MJ; Martínez-Castro P
Eur J Haematol; 2007 Jan; 78(1):66-71. PubMed ID: 17042772
[TBL] [Abstract][Full Text] [Related]
31. The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis.
Adams PC; Deugnier Y; Moirand R; Brissot P
Hepatology; 1997 Jan; 25(1):162-6. PubMed ID: 8985284
[TBL] [Abstract][Full Text] [Related]
32. Clinically overt hereditary hemochromatosis in Denmark 1948-1985: epidemiology, factors of significance for long-term survival, and causes of death in 179 patients.
Milman N; Pedersen P; á Steig T; Byg KE; Graudal N; Fenger K
Ann Hematol; 2001 Dec; 80(12):737-44. PubMed ID: 11797115
[TBL] [Abstract][Full Text] [Related]
33. Hereditary hemochromatosis.
Walker EM; Wolfe MD; Norton ML; Walker SM; Jones MM
Ann Clin Lab Sci; 1998; 28(5):300-12. PubMed ID: 9784832
[TBL] [Abstract][Full Text] [Related]
34. A prospective study of iron overload management in allogeneic hematopoietic cell transplantation survivors.
Majhail NS; Lazarus HM; Burns LJ
Biol Blood Marrow Transplant; 2010 Jun; 16(6):832-7. PubMed ID: 20079863
[TBL] [Abstract][Full Text] [Related]
35. Hemochromatosis. More common than you think.
Borgaonkar MR
Can Fam Physician; 2003 Jan; 49():36-43. PubMed ID: 12602841
[TBL] [Abstract][Full Text] [Related]
36. Review article: the iron overload syndromes.
Siddique A; Kowdley KV
Aliment Pharmacol Ther; 2012 Apr; 35(8):876-93. PubMed ID: 22385471
[TBL] [Abstract][Full Text] [Related]
37. Effects of phlebotomy therapy on cytochrome P450 2e1 activity and oxidative stress markers in dysmetabolic iron overload syndrome: a randomized trial.
Lainé F; Reymann JM; Morel F; Langouët S; Perrin M; Guillygomarc'h A; Brissot P; Turmel V; Mouchel C; Pape D; Bellissant E; Deugnier Y
Aliment Pharmacol Ther; 2006 Oct; 24(8):1207-13. PubMed ID: 17014579
[TBL] [Abstract][Full Text] [Related]
38. [Primary hemochromatosis in asymptomatic young patients].
Muñoz Sánchez MM; Núñez Martínez O; Torres Orgaz A; del Castillo Rueda A; de Portugal Alvarez J
An Med Interna; 2000 Jan; 17(1):9-12. PubMed ID: 10730398
[TBL] [Abstract][Full Text] [Related]
39. A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C: a multicenter, prospective, randomized, controlled trial in Japan.
Yano M; Hayashi H; Yoshioka K; Kohgo Y; Saito H; Niitsu Y; Kato J; Iino S; Yotsuyanagi H; Kobayashi Y; Kawamura K; Kakumu S; Kaito M; Ikoma J; Wakusawa S; Okanoue T; Sumida Y; Kimura F; Kajiwara E; Sata M; Ogata K
J Gastroenterol; 2004 Jun; 39(6):570-4. PubMed ID: 15235875
[TBL] [Abstract][Full Text] [Related]
40. Diagnosis and current treatments for primary iron overload.
Brissot P
Am J Hematol; 2007 Dec; 82(12 Suppl):1140-1. PubMed ID: 17963250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
